• Home
  •  / Johnson & Johnson

Johnson & Johnson

OverviewSuggest Edit

Johnson & Johnson is a global holding company that engages in the research and development, manufacture and sale of a range of products in the healthcare field. The company operates in three business segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health, and wound care markets. The Pharmaceutical segment is focused on the therapeutic areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolism, as well as pulmonary hypertension. The Medical Devices segment includes a range of products used in the orthopedic, surgery, interventional solutions, and eye health fields.

Its major brands include:

TypePublic
Founded1886
HQNew Brunswick, NJ, USMap
Websitejnj.com
Employee Ratings4.2More
Overall CultureCMore
View Jobs (1,966)

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2019)132,200(-2%)
Job Openings1,966
Revenue (FY, 2019)$82.1 B
Share Price (Jun 2021)$165(-1%)
Cybersecurity ratingDMore

Key People/Management at Johnson & Johnson

Alex Gorsky

Alex Gorsky

Chairman, Board of Directors and Chief Executive Officer
Joaquin Duato

Joaquin Duato

Vice Chairman of the Executive Committee
Peter Fasolo

Peter Fasolo

Executive Vice President, Chief Human Resources Officer
Thibaut Mongon

Thibaut Mongon

Executive Vice President, Worldwide Chairman, Consumer Health
Paul Stoffels

Paul Stoffels

Vice Chairman of the Executive Committee and Chief Scientific Officer
Michael Sneed

Michael Sneed

Executive Vice President, Global Corporate Affairs & Chief Communication Officer
Show more

Johnson & Johnson Office Locations

Johnson & Johnson has offices in New Brunswick, Jacksonville, Lancaster, Piscataway and in 64 other locations
New Brunswick, NJ, US (HQ)
1 Johnson And Johnson Plaza
Jacksonville, FL, US
7500 Centurion Pkwy N
Lancaster, PA, US
1838 Colonial Village Ln
Piscataway, NJ, US
425 NJ-18
Buenos Aires, AR
Mendoza 1259
Chippendale, AU
5 Broadway
Show all (71)

Johnson & Johnson Financials and Metrics

Johnson & Johnson Revenue

Embed Graph
View revenue for all periods
Johnson & Johnson's revenue was reported to be $82.06 b in FY, 2019 which is a 0.6% increase from the previous period.
USD

Revenue (Q3, 2020)

21.1b

Gross profit (Q3, 2020)

14.1b

Gross profit margin (Q3, 2020), %

66.9%

Net income (Q3, 2020)

3.6b

Market capitalization (11-Jun-2021)

434.4b

Closing stock price (11-Jun-2021)

165.0

Cash (27-Sept-2020)

19.0b

EV

453.2b
Johnson & Johnson's current market capitalization is $434.4 b.
Annual
USDFY, 2017FY, 2018FY, 2019

Revenue

76.5b81.6b82.1b

Revenue growth, %

6%7%1%

Cost of goods sold

25.4b27.1b27.6b

Gross profit

51.1b54.5b54.5b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

17.8b18.8b19.7b20.0b20.8b20.3b20.0b20.6b20.7b20.7b18.3b21.1b

Cost of goods sold

5.4b5.8b6.9b6.6b6.9b6.6b6.6b6.9b6.9b7.1b6.6b7.0b

Gross profit

12.4b13.0b12.7b13.4b13.9b13.8b13.4b13.6b13.9b13.6b11.8b14.1b

Gross profit Margin, %

70%69%65%67%67%68%67%66%67%66%64%67%
show all
Annual
USDFY, 2017FY, 2018FY, 2019

Cash

17.8b18.1b17.3b

Accounts Receivable

13.5b14.1b14.5b

Prepaid Expenses

2.5b2.7b2.4b

Inventories

8.8b8.6b9.0b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

20.9b12.6b15.7b14.6b17.6b16.1b14.7b14.4b16.2b15.5b11.2b19.0b

Accounts Receivable

12.3b13.3b13.2b14.2b14.1b14.0b14.1b14.7b14.8b14.9b14.6b14.6b

Prepaid Expenses

2.8b3.0b2.9b2.6b2.6b2.9b2.6b2.4b2.2b2.4b2.6b2.5b

Inventories

8.9b9.7b9.5b9.0b8.8b8.7b9.1b9.3b9.2b8.9b9.4b9.6b
show all
Annual
USDFY, 2017FY, 2018FY, 2019

Net Income

1.3b15.3b15.1b

Depreciation and Amortization

5.6b6.9b7.0b

Inventories

581.0m(644.0m)(277.0m)

Accounts Payable

2.7b4.0b4.1b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

4.4b8.2b12.0b4.4b8.3b12.3b3.7b9.4b11.1b5.8b9.4b13.0b

Depreciation and Amortization

912.0m2.1b3.8b1.7b3.5b5.2b1.8b3.5b5.2b1.7b3.5b5.3b

Inventories

(368.0m)(421.0m)(193.0m)(322.0m)(491.0m)(777.0m)(369.0m)(423.0m)(424.0m)(159.0m)(637.0m)(784.0m)

Accounts Payable

(2.0b)(1.2b)339.0m(1.7b)(49.0m)731.0m(1.8b)(444.0m)2.3b(2.5b)(2.3b)(119.0m)
show all
USDQ1, 2018

Debt/Equity

0.5 x

Debt/Assets

0.2 x

Financial Leverage

2.1 x
Show all financial metrics

Johnson & Johnson Operating Metrics

FY, 2016FY, 2017Jun, 2018FY, 2018FY, 2019

Manufacturing Facilities

11912511197

Countries

606060

Distribution Centers

350

Suppliers

3.5 k
Show all operating metrics

Johnson & Johnson Acquisitions / Subsidiaries

Company NameDateDeal Size
Momenta PharmaceuticalsAugust 19, 2020$6.5 b
TARIS BiomedicalDecember 20, 2019
Verb SurgicalDecember 20, 2019
Auris HealthJanuary 23, 2019$3.4 b
Ci:z HoldingsOctober 23, 2018$2.1 b
Zarbee's NaturalsJuly 27, 2018
OrthotaxyFebruary 20, 2018
Actelion PharmaceuticalsJanuary 26, 2017$30 b
Abott Medical OpticsSeptember 16, 2016$4.33 b
Vogue InternationalJune 02, 2016$3.3 b
Show more

Johnson & Johnson Revenue Breakdown

Embed Graph

Johnson & Johnson revenue breakdown by business segment: 31.6% from Medical Devices, 51.4% from Pharmaceutical and 16.9% from Consumer

Johnson & Johnson revenue breakdown by geographic segment: 19.0% from Asia-Pacific, Africa, 7.2% from Western Hemisphere excluding US, 22.5% from Europe and 51.3% from United States

Human Capital Metrics

Embed Graph
Show all human capital metrics

Johnson & Johnson Cybersecurity Score

Cybersecurity ratingPremium dataset

D

67/100

Learn more about our premium products
SecurityScorecard logo

Johnson & Johnson Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

60-79

out of 100

Learn more about our premium products
CSRHub logo

Johnson & Johnson Online and Social Media Presence

Johnson & Johnson's Trends

Embed Graph

Johnson & Johnson Company Culture

  • Overall Culture

    C

    71/100

  • CEO Rating

    D-

    62/100

  • Compensation

    D

    54/100

Learn more on Comparably

Johnson & Johnson News and Updates

June 14, 2021

Global WholeHealth Partners Corp. (GWHP-OTC) Acquires Rights to Distribute & Sell Johnson & Johnson COVID-19 Vaccine

SAN CLEMENTE, CA, June 14, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Global WholeHealth Partners Corp. (OTC: GWHP), a company that offers one of the largest lines of COVID 19 tests, including SARS-CoV-2 viruses, and that states that its Antibody IgG/IgM tests that they offer are capable of detec…
June 11, 2021

Johnson & Johnson has to throw away 60 million vaccine doses because of possible contamination at the beleaguered Emergent BioSolutions plant

Summary List PlacementThe Food and Drug Administration has told Johnson & Johnson to throw out about 60 million COVID-19 vaccine doses from a beleaguered plant, people familiar with the situation told The New York Times. The vaccine doses were made at a factory for Emergent BioSolutions, a bio…
June 11, 2021

FDA Reportedly Set To Approve Johnson & Johnson Doses From Facility Shut Down For Bad Batches

The FDA is likely to approve 10 million doses of the Johnson & Johnson Covid-19 vaccine as soon as Friday from the factory the agency shut down in April for ruining millions of doses, according to a CNN report.
June 10, 2021

U.S. government STOPS all new shipments of Johnson & Johnson COVID-19 vaccine so states can clear backlog of expiring doses as FDA extends shelf life by six weeks

The U.S. government has stopped all new shipments of the Johnson & Johnson COVID-19 shot so vaccination sites can clear a logjam of unused doses before they expire.
June 10, 2021

U.S. Officials Extend Expiration Dates On Johnson & Johnson Vaccine Doses

It comes after an FDA review found the shots remained safe and effective for an extra six weeks.
June 10, 2021

FDA extends shelf life of Johnson & Johnson Covid-19 vaccine

Johnson & Johnson said on Thursday the U.S. Food and Drug Administration has extended the shelf life of its single-shot Covid-19 vaccine from three months to four-and-a-half months.
Show more

Johnson & Johnson Blogs

June 02, 2021

New Phase 3b Psoriatic Arthritis (PsA) Data Show First-in-Class TREMFYA® (guselkumab) Achieved Robust Joint Symptom Improvement and Complete Skin Clearance in Patients with Inadequate Response to Tumor Necrosis Factor Inhibition (TNFi-IR)

June 01, 2021

Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs

Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs Liz.McPherson@… Tue, 06/01/2021 - 11:31 Janssen Highlights Commitment to Advancing Transformative …
June 01, 2021

Janssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma

June 01, 2021

Janssen Reports New Data for BCMA CAR-T, Cilta-Cel, Showing Deep and Durable Responses in Patients with Relapsed or Refractory Multiple Myeloma

May 26, 2021

Updated Data Demonstrate Significant Improvement in Hematologic Complete Response with DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis

May 26, 2021

Long-Term ERLEADA® (apalutamide) Patient-Reported Outcomes Data in Metastatic Castration-Sensitive Prostate Cancer Demonstrate Maintenance of Health-Related Quality of Life for Patients

Show more

 Johnson & Johnson Frequently Asked Questions

  • When was Johnson & Johnson founded?

    Johnson & Johnson was founded in 1886.

  • Who are Johnson & Johnson key executives?

    Johnson & Johnson's key executives are Alex Gorsky, Joaquin Duato and Peter Fasolo.

  • How many employees does Johnson & Johnson have?

    Johnson & Johnson has 132,200 employees.

  • What is Johnson & Johnson revenue?

    Latest Johnson & Johnson annual revenue is $82.1 b.

  • What is Johnson & Johnson revenue per employee?

    Latest Johnson & Johnson revenue per employee is $620.7 k.

  • Who are Johnson & Johnson competitors?

    Competitors of Johnson & Johnson include Boston Scientific, GSK and Estee Lauder.

  • Where is Johnson & Johnson headquarters?

    Johnson & Johnson headquarters is located at 1 Johnson And Johnson Plaza, New Brunswick.

  • Where are Johnson & Johnson offices?

    Johnson & Johnson has offices in New Brunswick, Jacksonville, Lancaster, Piscataway and in 64 other locations.

  • How many offices does Johnson & Johnson have?

    Johnson & Johnson has 71 offices.